Great Researcher 2 - Revision history

JimmyLanglois4 at 16:22, 30 December 2020

2020-12-30T16:22:55Z

ChristopherNsy at 16:12, 30 December 2020

2020-12-30T16:12:36Z

CarrollCampos7: Created page with "Two times as much is spent per individual on healthcare in the united states and at a far less standard than that associated with any typical Western country. So what then hap..."

2020-12-30T16:04:45Z

Created page with "Two times as much is spent per individual on healthcare in the united states and at a far less standard than that associated with any typical Western country. So what then hap..."

New page

Two times as much is spent per individual on healthcare in the united states and at a far less standard than that associated with any typical Western country. So what then happens to the extra funds? Operating costs claim a sizable amount of these funds, however a big portion of it makes up the profits. By way of example, money is invested in companies like these and in return investors will get the profit by means of total annual dividends. researcher do?" style="max-width:420px;float:left;padding:10px 10px 10px 0px;border:0px;">Not every organisation's profits go directly back to its investors, several of the funds will go towards the research of new ways through which more revenue may be yielded. In view of Clinical institutions, this would involve research into new methods, drugs or apparatus, helping us to take advantage of this in the long term. As such, should the US changes to public medicine, what will it do for Medical Research? If these companies are no longer making such large profits, will this mean clinical research efforts can no longer be funded? There are actually growing apprehension that advances in clinical Research will be stalled if the majority of public funding is committed to public medicine. Conversely, this is not the only funding accessible for Medical Research; the United Kingdom spends great sums of cash for the point of Medical Research and is home to large proportion of Clinical Research Organisations throughout the globe. A large amount of the public are hoping the united states government will rethink their strategy while moving the country to public medicine, and continue to invest in Medical Research. Some believe that the government is persuaded to focus on treatments that have the greatest possibility to generate profit compared to those which most beneficial health wise. Cellular therapy is a breakthrough process of treating diseases through integrating new cells into a tissue. It really is completed by transplanting a tissue from an organ, fetus, or embryo, that may be injected to recipients with a disease caused by unhealthy tissues and organs. The new cells are meant to regenerate damaged tissues and make them function normally once again. Organs like the adrenals, thyroid and pituitary glands, liver, kidney, ovary and testis, thymus, parotid, spleen, pancreas, heart, and also the brain, are often treated with this kind of therapy. It really is a sort of regenerative medicine proven to be effective as well as shown to cure a number of hereditary diseases. Its roots may be traced in 1912, after some physicians treated children with hypothyroid through injecting thyroid cells. Some claim that as early as the 1800s, Dr. Charles-Edward Brown Sequard used extracts from animal testicle in attempt of stopping the effects of aging among humans. This was followed by Dr. Paul Niehans, who developed the therapy and practiced it in Sweden. He was later deemed as the "Father of Cellular Therapy." It is [https://git.sicom.gov.co/colinhndrcks just click the up coming web site] like the process of bone marrow transplant, where the stem cells within the bone marrow are removed and cleaned, and injected to a person to cure a particular disease like leukemia. You will discover two types of cellular therapy, the autologous and allogeneic. Autologous therapy involves extracting of cells from a patient and after that injecting it back to the exact same patient. This kind of cell transplant is often used as treatment for diseases which require an exact genetic match. Failure to provide such a compatible sample of cells or tissue can cause severe infection, worsened illness, and also death. Should the patient survives, the incompatible tissue shall need to be removed. The other type is the allogeneic. Between the 2, this really is the process normally performed. The stem cell donor may be another person with the exact same tissue type. Siblings tend to be the most ideal donors because tissue types have probability of 25 to thirty percent being alike. In some cases, these cells are preserved for future doses while some are manufactured. These manufactured cells can cure up to a hundred patients. Preserving these cells will be the most critical part, as the effectiveness and genetic composition has to be retained. Diseases like stroke, diabetes, and disorders of the nervous system tend to be cured with this sort of therapy.

← Older revision		Revision as of 16:22, 30 December 2020
Line 1:		Line 1:
−	Big data ~~within~~ the ~~health care~~ industry ~~will be close to~~ to get even bigger due to the move toward electronic ~~health~~ reports. Electronic medical records are receiving a boost ~~as a result~~ of the implementation of the Affordable Care Act. ~~For this reason~~, medical researchers may ~~expect~~ an enormous influx of healthcare data to analyze.<br><br>The scientific community is abuzz about the ~~potential for~~ big data within the medical research arena. ~~According to~~ Science 2.0, a science blog, ~~several~~ of the clearest opportunities recently identified in this area revolve around reducing costs in several key areas:<br><br>High-cost patients - Did you realize that just five percent of patients account for roughly half of all US healthcare costs? By targeting these high-cost patients, big data has the ~~potential~~ to make ~~an enormous effect~~ on total healthcare spending ~~in the nation~~. This really is ~~the best~~ example of the Pareto principle at the job.<br><br>Readmissions - With nearly one third of readmissions deemed to be preventable, using big data to predict which patients are at a high risk of readmission could lead to better interventions and reduced re-admissions.<br><br>Triage - Big data could be used to improve the triage process by applying algorithms to send patients to the correct unit for care and ensuring that everyone associated with providing that care is promptly informed ~~through~~ the process.<br><br>Decompensation - Decompensation refers to a patient's worsening health condition. Patient monitoring tools ~~for example~~ heart rate and blood pressure monitors are used to measure a patient's current condition. Using big data, researchers ~~could possibly~~ be better able to determine the risk of decompensation, allowing healthcare providers to intervene ~~ahead of~~ the patient's condition worsens.<br><br>Adverse events - ~~Nobody~~ desires to ~~experience~~ an adverse health event ~~for example~~ infection, a drug reaction, or renal failure. These events often cause death, yet ~~are often~~ preventable. Big data could make huge gains in both preventing adverse events and slashing their associated costs.<br><br>Diseases affecting multiple organ systems - Systemic diseases that affect multiple organ systems are among-the costliest to treat and manage. Using big data, medical researchers ~~may~~ be better able to predict the likely progression of a disease which, ~~sequentially~~, would help healthcare providers develop a ~~far~~ more effective, ~~and many~~ more cost-effective, plan ~~for treatment~~.<br><br>While these areas all represent significant opportunities for medical researchers ~~as well as~~ the medical ~~industry~~ at large, how can researchers possibly make ~~sense~~ of all that data? In line with Dolphin, "Big Data relates to the ~~truth~~ that today's business intelligence systems are experiencing record levels of data growth from terabytes to petabytes and beyond. The challenge is in maximizing the opportunity for real-time business intelligence while minimizing the impact of exploding data volume on productivity and total cost of ownership (TCO)."<br><br>This really is done ~~through~~ the usage of business intelligence and ~~[http://www.iesanjuandedamasco.edu.co/social/members/colinhndrcks/activity cellular therapy]~~ data archiving software. With the proper tools in hand, medical researchers ~~have~~ the ~~ability~~ to make feeling of the sheer volumes of healthcare data from the past, present, and future.	+	Big data in the healthcare industry is about to get even bigger due to the move toward electronic medical reports. Electronic medical records are receiving a boost because of the implementation of the Affordable Care Act. Therefore, medical researchers may anticipate an enormous influx of healthcare data to analyze.<br><br>The scientific community is abuzz about the possibility of big data within the medical research arena. Based on Science 2.0, a science blog, some of the clearest opportunities recently identified in this particular area revolve around reducing costs in several key areas:<br><br>High-cost patients - Did you realize that just five percent of patients account for roughly half of all US healthcare costs? By targeting these high-cost patients, big data has the possibility to make a tremendous impact on total healthcare spending inside america. This really is a good example of the Pareto principle at the job.<br><br>Readmissions - With nearly one-third of readmissions deemed to be preventable, using big data to predict which patients are at a high risk of readmission could lead to better interventions and reduced re-admissions.<br><br>Triage - Big data could also be used to improve the triage process by applying algorithms to send patients to the correct unit for care and ensuring that everyone associated with providing that care is promptly informed throughout the process.<br><br>Decompensation - Decompensation refers to a patient's worsening health condition. Patient monitoring tools such as heart rate and blood pressure level monitors are used to measure a patient's current condition. Using big data, researchers may be better able to determine the risk of decompensation, allowing healthcare providers to intervene prior to the [https://clasesremotas.edu.do/members/reginaldkumar quality patient care]'s condition worsens.<br><br>Adverse events - No-one desires to suffer from an adverse health event such as infection, a drug reaction, or renal failure. These events often cause death, yet tend to be preventable. Big data could make huge gains in both preventing adverse events and slashing their associated costs.<br><br>Diseases affecting multiple organ systems - Systemic diseases that affect multiple organ systems are among-the costliest to treat and manage. Using big data, medical researchers could possibly be better able to predict the likely progression of a disease which, in turn, would help healthcare providers develop a more effective, as well as more cost-effective, plan of action.<br><br>While these areas all represent significant opportunities for medical researchers and the medical sector at large, how can researchers possibly make feeling of all that data? In line with Dolphin, "Big Data relates to the very fact that today's business intelligence systems are experiencing record levels of data growth from terabytes to petabytes and beyond. The challenge is in maximizing the opportunity for real-time business intelligence while minimizing the impact of exploding data volume on productivity and total cost of ownership (TCO)."<br><br>This really is done over the usage of business intelligence and data archiving software. With the proper tools in hand, medical researchers possess the capability to make feeling of the sheer volumes of healthcare data from the past, present, and future.

← Older revision		Revision as of 16:12, 30 December 2020
Line 1:		Line 1:
−	~~Two times as much is spent per individual on healthcare in~~ the ~~united states and at a far less standard than that associated with any typical Western country. So what then happens~~ to the ~~extra funds? Operating costs claim~~ a ~~sizable amount~~ of ~~these funds, however a big portion~~ of ~~it makes up~~ the ~~profits~~. ~~By way of example~~, ~~money is invested in companies like these and in return investors will get the profit by means~~ of ~~total annual dividends~~.<br><br>~~researcher do?" style="max-width:420px;float:left;padding:10px 10px 10px 0px;border:0px;">Not every organisation's profits go directly back to its investors, several of~~ the ~~funds will go towards~~ the research ~~of new ways through which more revenue may be yielded~~. ~~In view of Clinical institutions~~, ~~this would involve research into new methods~~, ~~drugs or apparatus, helping us to take advantage~~ of this in ~~the long term.~~<br><br>~~As such, should the~~ US ~~changes to public medicine, what will it do for Medical Research~~? If these ~~companies are no longer making such large profits~~, ~~will this mean clinical research efforts can no longer be funded? There are actually growing apprehension that advances~~ in ~~clinical Research will be stalled if~~ the ~~majority of public funding is committed to public medicine~~. ~~Conversely, this~~ is ~~not~~ the ~~only funding accessible for Medical Research; the United Kingdom spends great sums~~ of ~~cash for~~ the ~~point of Medical Research and is home to large proportion of Clinical Research Organisations throughout~~ the ~~globe~~.<br><br>~~A large amount~~ of ~~the public are hoping the united states government will rethink their strategy while moving the country~~ to ~~public medicine~~, ~~and continue~~ to ~~invest in Medical Research. Some believe that the government is persuaded~~ to ~~focus on treatments that have the greatest possibility to generate profit compared to those which most beneficial health wise~~.<br><br>~~Cellular therapy is a breakthrough~~ process ~~of treating diseases through integrating new cells into a tissue. It really is completed~~ by ~~transplanting a tissue from an organ, fetus, or embryo, that may be injected~~ to ~~recipients with a disease caused by unhealthy tissues and organs. The new cells are meant~~ to ~~regenerate damaged tissues~~ and ~~make them function normally once again~~.<br><br>~~Organs like the adrenals, thyroid and pituitary glands, liver, kidney, ovary and testis, thymus, parotid, spleen, pancreas,~~ heart, and ~~also the brain,~~ are ~~often treated with this kind of therapy~~. ~~It really is a sort~~ of ~~regenerative medicine proven to be effective as well as shown~~ to ~~cure a number~~ of ~~hereditary diseases~~.<br><br>~~Its roots may be traced in 1912~~, ~~after some physicians treated children with hypothyroid through injecting thyroid cells~~. ~~Some claim that as early as the 1800s~~, Dr. ~~Charles-Edward Brown Sequard used extracts from animal testicle~~ in ~~attempt of stopping the effects of aging among humans. This was followed by Dr. Paul Niehans, who developed the therapy~~ and practiced it in Sweden. He was later deemed as the "Father of Cellular Therapy." It is [https://git.sicom.gov.co/colinhndrcks just click the up coming web site] like the process of bone marrow transplant, where the stem cells within the bone marrow are removed and cleaned, and injected to a person to cure a particular disease like leukemia.<br><br>~~You will discover two types of cellular therapy,~~ the ~~autologous~~ and ~~allogeneic~~. ~~Autologous therapy involves extracting of cells from a patient and after that injecting it back~~ to the ~~exact same patient. This kind~~ of ~~cell transplant is often used as treatment for diseases~~ which ~~require an exact genetic match. Failure to provide such~~ a ~~compatible sample of cells or tissue can cause severe infection, worsened illness~~, and ~~also death. Should the patient survives~~, ~~the incompatible tissue shall need to be removed~~.<br><br>~~The other type is~~ the ~~allogeneic. Between the 2~~, ~~this really is~~ the ~~process normally performed~~. The ~~stem cell donor may be another person with~~ the ~~exact same tissue type. Siblings tend to be~~ the ~~most ideal donors because tissue types have probability~~ of ~~25 to thirty percent being alike~~.<br><br>~~In some cases, these cells are preserved for future doses while some are manufactured~~. ~~These manufactured cells can cure up to a hundred patients~~. ~~Preserving these cells will be~~ the ~~most critical part~~, as the ~~effectiveness and genetic composition has~~ to ~~be retained. Diseases like stroke~~, ~~diabetes~~, and ~~disorders of the nervous system tend to be cured with this sort of therapy~~.	+	Big data within the health care industry will be close to to get even bigger due to the move toward electronic health reports. Electronic medical records are receiving a boost as a result of the implementation of the Affordable Care Act. For this reason, medical researchers may expect an enormous influx of healthcare data to analyze.<br><br>The scientific community is abuzz about the potential for big data within the medical research arena. According to Science 2.0, a science blog, several of the clearest opportunities recently identified in this area revolve around reducing costs in several key areas:<br><br>High-cost patients - Did you realize that just five percent of patients account for roughly half of all US healthcare costs? By targeting these high-cost patients, big data has the potential to make an enormous effect on total healthcare spending in the nation. This really is the best example of the Pareto principle at the job.<br><br>Readmissions - With nearly one third of readmissions deemed to be preventable, using big data to predict which patients are at a high risk of readmission could lead to better interventions and reduced re-admissions.<br><br>Triage - Big data could be used to improve the triage process by applying algorithms to send patients to the correct unit for care and ensuring that everyone associated with providing that care is promptly informed through the process.<br><br>Decompensation - Decompensation refers to a patient's worsening health condition. Patient monitoring tools for example heart rate and blood pressure monitors are used to measure a patient's current condition. Using big data, researchers could possibly be better able to determine the risk of decompensation, allowing healthcare providers to intervene ahead of the patient's condition worsens.<br><br>Adverse events - Nobody desires to experience an adverse health event for example infection, a drug reaction, or renal failure. These events often cause death, yet are often preventable. Big data could make huge gains in both preventing adverse events and slashing their associated costs.<br><br>Diseases affecting multiple organ systems - Systemic diseases that affect multiple organ systems are among-the costliest to treat and manage. Using big data, medical researchers may be better able to predict the likely progression of a disease which, sequentially, would help healthcare providers develop a far more effective, and many more cost-effective, plan for treatment.<br><br>While these areas all represent significant opportunities for medical researchers as well as the medical industry at large, how can researchers possibly make sense of all that data? In line with Dolphin, "Big Data relates to the truth that today's business intelligence systems are experiencing record levels of data growth from terabytes to petabytes and beyond. The challenge is in maximizing the opportunity for real-time business intelligence while minimizing the impact of exploding data volume on productivity and total cost of ownership (TCO)."<br><br>This really is done through the usage of business intelligence and [http://www.iesanjuandedamasco.edu.co/social/members/colinhndrcks/activity cellular therapy] data archiving software. With the proper tools in hand, medical researchers have the ability to make feeling of the sheer volumes of healthcare data from the past, present, and future.